Chromosomal breakpoints and changes in DNA copy number in refractory acute myeloid leukemia

Leukemia

Volumn 11, Issue 7, 1997, Pages 958-963

  Ei Rifai, W ^a,b   Elonen, E ^c   Larramendy, M ^a,d   Ruutu, T ^c   Knuutila, S ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NATIONAL RESEARCH CENTRE   (Egypt)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d FACULTAD DE CIENCIAS NATURALES Y MUSEO   (Argentina)

Author keywords

12p; 5q; 7q; CGH; Refractory AML

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CHROMOSOME 12P; CHROMOSOME 5Q; CHROMOSOME 7Q; CHROMOSOME 8Q; CHROMOSOME ABERRATION; CHROMOSOME BREAKAGE; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE NUMBER; HUMAN; KARYOTYPE; MALE; PRIORITY JOURNAL; PROGNOSIS;

EID: 0030795838     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400706     Document Type: Article

References (13)

1. Leith CP, Chen IM, Kopecky KJ, Appelbaum FR, Head DR, Godwin JE, Weick JK, Willman CL. Correlation of multidrug resistance (MDR1) protein expression with functional dye/drug efflux in acute myeloid leukemia by multiparameter flow cytometry: identification of discordant MDR-/efflux+ and MDR1+/efflux- cases. Blood 1995; 86: 2329-2342.
2. Preisler HD, Larson RA, Raza A, Browman G, Goldberg J, Vogler R, Day R, Gottlieb A, Vardiman JW, Bennett J et al. The treatment of patients with newly diagnosed poor prognosis acute myelogenous leukaemia: response to treatment and treatment failure. Br J Haematol 1991; 79: 390-397.
3. Bishop JF. Does it matter how remission is achieved in acute leukemia? Leukemia 1996; 10 (Suppl. 1): S7-S9.
4. Biggs JC, Horowitz MM, Gale RP, Ash RC, Atkinson K, Helbig W, Jacobsen N, Phillips GL, Rimm AA, Ringden O et al. Bone marrow transplants may cure patients with acute leukemia never achieving remission with chemotherapy. Blood 1992; 80: 1090-1093.
5. List AF, Spier CM. Multidrug resistance in acute leukemia: a conserved physiologic function. Leuk Lymphoma 1992; 8: 9-14.
6. Hiddemann W, Martin WR, Sauerland CM, Heinecke A, Buchner T. Definition of refractoriness against conventional chemotherapy in acute myeloid leukemia: a proposal based on the results of retreatment by thioguanine, cytosine arabinoside, and daunorubicin (TAD 9) in 150 patients with relapse after standardized first line therapy. Leukemia 1990; 4: 184-188.
7. Casanovas R-O, Solary E, Campos L, Maynadie M, Favre M, Bermend J-L, Garand R, Bén M-C, Faure G, Leucémies GdEld. Prognostic relevance of surface markers in adults de novo acute myeloid leukemias: a prospective study of the Group d'Etude Immunologique des Leucémies (GEIL). Leuk Lymphoma 1994; 13: 7-10.
8. Borowitz MJ, Gockerman JP, Moore JO, Civin CI, Page SO, Robertson J, Bigner SH. Clinicopathologic and cytogenic features of CD34 (My 10)-positive acute nonlymphocytic leukemia. Am I Clin Pathol 1989; 91: 265-270.
9. Bradstock K, Matthews J, Benson E, Page F, Bishop J, group ALS. Prognostic value of immunophenotyping in acute myeloid leukemia. Blood 1994; 84: 1220-1225.
10. de Silva M, Kantharidis P, Wall DM, Campbell L, Vrazas V, Nadalin G, Kaczmarczyk SJ, Hu XF, Parkin JD, Zalcberg JR. Inheritance of chromosome 7 is associated with a drug-resistant phenotype in somatic cell hybrids. Br J Haematol 1996; 73: 169-174.
11. Dastugue N, Payen C, Lafage Pochitaloff M, Bernard P, Leroux D, Huguet Rigal F, Stoppa AM, Marit G, Molina L, Michallet M, Maraninchi D, Attal M, Reiffers J. Prognostic significance of karyotype in de novo adult acute myeloid leukemia. The BGMT group. Leukemia 1995; 9: 1491-1498.
12. Bloomfield CD, de la Chapelle A. Chromosome abnormalities in acute nonlymphocytic leukemia. Semin Oncol 1987; 14: 372-383.
13. Freireich EJ, Cork A, Stass SA, McCredie KB, Keating MJ, Estey EH, Kantarjian HM, Trujillo JM. Cytogenetics for detection of minimal residual disease in acute myeloblastic leukemia. Leukemia 1992; 6: 500-506.